Cargando…

Disease-modifying agents in multiple sclerosis

Since 1993, six disease-modifying therapies for multiple sclerosis (MS) have been proven to be of benefit in rigorous phase III clinical trials. Other agents are also available and are used to treat MS, but definitive data on their efficacy is lacking. Currently, disease-modifying therapy is used fo...

Descripción completa

Detalles Bibliográficos
Autor principal: Coyle, P. K.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824955/
https://www.ncbi.nlm.nih.gov/pubmed/20182575
http://dx.doi.org/10.4103/0972-2327.58280

Ejemplares similares